drugset / Trial / NCT00003802
Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
Phase 2
Completed
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of pyrazoloacridine in treating patients who have metastatic skin or eye melanoma.
Timeline
- Start
- 1999-02
- Primary completion
- —
- Completion
- 2002-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pyrazoloacridine | Small molecule | — | Intravenous |